CSG Actuarial has added a new Medicare Supplement Health Condition and Medication Underwriting Filter to the MarketAdvisor quoting tool which will display carriers that will accept selected health conditions and medications. The table below is a sample of medications declined by the top Medicare Supplement carriers.
|Medication||% of Companies that Decline||Conditions Associated with Medication|
|Abilify||60%||Bipolar Disorder, Depression, Psychosis, Schizophrenia|
|Betapace||30%||Arrhythmias, Atrial Fibrillation|
|Cerefolin||60%||Alzheimer's Disease, Dementia|
|Dolophine||30%||Opioid Analgesic, Opioid Dependence, Severe Pain|
|Enbrel||50%||Plaque Psoriasis, Rheumatoid Arthritis|
|Humira||45%||Crohn's Disease, Rheumatoid Arthritis|
|Kadian||25%||Chronic or Severe Pain|
|Letairis||50%||Cancer, Pulmonary Hypertension|
|Natrecor||55%||Congestive Heart Failure|
|Plavix||40%||Angioplasty, Blood Thinner, Stroke, Stroke Prevention|
|Rilutek||70%||ALS/Lou Gehrig’s Disease|
|Viadur||35%||Cancer, Prostate Cancer|
About CSG Actuarial
CSG Actuarial monitors insurance markets to provide the most up-to-date competitive intelligence in the industry. CSG’s MarketAdvisor™ Quoting Tools include premium rate and underwriting information for more than 300 companies.